KNP-102

N/A

Report date: 2024/11/13 14:22:13

Base Information

Drug NameKNP-102

Drug Alias NameKNP-102

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-12 receptor inhibitors

TargetsInterleukin-12 receptor

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKanaph Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKanaph Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A